Most Recent
Qantas wins approval for “Qantas Assure” trade mark
Qantas has successfully defended against a challenge to its bid to trade mark the term "Qantas Assure", with the Registrar of Trade marks saying the inclusion of the notorious Qantas mark in the term made consumer confusion unlikely.
Industry groups appeal FWC approval of CFMEU merger
Industry groups filed an appeal yesterday of a Fair Work Commission decision that granted approval to the merger of the Construction, Forestry, Mining and Energy Union with two other unions.
Bunnings defeats challenge to Sydney development plans
Bunnings Properties Pty Ltd has defeated a challenge brought by the Ku-ring-gai Council to its plans for development at the site of the former 3M building in a Sydney suburb.
Cargill’s talks with Allens stay privileged in Viterra case
Viterra Malt has come up short in a second bid to access communications between Cargill Australia and its lawyers, in a case alleging fraudulent concealment by Viterra in its $420 million sale of malt producer Joe White Maltings to Cargill Australia in 2013.
Campbell Soup can’t trade mark “Fruits and Roots”
Campbell Soup Co. has lost its bid to trade mark the phrase "Fruits and Roots" for beverages, with an IP Australia delegate saying the food giant had not proven the mark could distinguish its products.
Fairfax loses fight to block realestate.com.au trade mark
Fairfax Media has lost a bid to stop online property advertising company REA Group from trademarking its web address realestate.com.au.
Shine sets sights on new target in pelvic mesh class action
As Shine Lawyers awaits judgment in a marathon class action against Johnson & Johnson over its pelvic mesh implants, a separate class action by the firm kicked into gear Wednesday when a judge gave the ok to serve court papers on US-based American Medical Systems.
Melbourne breweries battle over “ale” trade marks
Melbourne-based Collins St Brewing has sued rival artisanal brewer La Sirene for allegedly violating its "urban ale" trade mark.
Ex-Provident Capital director can appeal ASIC ban
The former head of collapsed debenture firm Provident Capital has gotten court approval to appeal a ruling banning him from managing companies.
GSK, Novartis concede more ground in ACCC’s Voltaren case
GlaxoSmithKline and Novartis have made another admission in a case brought by the ACCC alleging the drug giants made misleading claims in marketing their Voltaren Osteo Gel and Voltaren Emulgel pain relief products.